Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Encision has an operating margin of -2.6%, meaning the company retains $-3 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -9.7% the prior year.
Encision's revenue declined 0.5% year-over-year, from $6.6M to $6.6M. This contraction results in a growth score of 27/100.
Encision carries a low D/E ratio of 1.22, meaning only $1.22 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 66/100, indicating a strong balance sheet with room for future borrowing.
Encision's current ratio of 1.66 indicates adequate short-term liquidity, earning a score of 46/100. The company can meet its near-term obligations, though with limited headroom.
While Encision generated -$55K in operating cash flow, capex of $54K consumed most of it, leaving -$109K in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Encision passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Encision generates $0.25 in operating cash flow (-$55K OCF vs -$220K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Encision earns $-3.9 in operating income for every $1 of interest expense (-$172K vs $44K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
This page shows Encision (ECIA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Encision generated $6.6M in revenue in fiscal year 2025. This represents a decrease of 0.5% from the prior year.
Encision's EBITDA was -$91K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 83.7% from the prior year.
Encision generated -$109K in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 182.6% from the prior year.
Encision reported -$220K in net income in fiscal year 2025. This represents an increase of 68.2% from the prior year.
Encision earned $-0.02 per diluted share (EPS) in fiscal year 2025. This represents an increase of 66.7% from the prior year.
Encision held $257K in cash against $0 in long-term debt as of fiscal year 2025.
Encision had 12M shares outstanding in fiscal year 2025. This represents an increase of 0.2% from the prior year.
Encision's gross margin was 53.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 5.9 percentage points from the prior year.
Encision's operating margin was -2.6% in fiscal year 2025, reflecting core business profitability. This is up 7.1 percentage points from the prior year.
Encision's net profit margin was -3.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 7.1 percentage points from the prior year.
Encision invested $593K in research and development in fiscal year 2025. This represents a decrease of 4.6% from the prior year.
Encision invested $54K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 351.6% from the prior year.
ECIA Income Statement
| Metric | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5M-4.7% | $1.6M+1.1% | $1.6M-9.7% | $1.8M+7.6% | $1.6M+3.1% | $1.6M-13.4% | $1.8M+10.5% | $1.7M |
| Cost of Revenue | $831K+14.7% | $724K-1.5% | $735K-20.7% | $927K+34.7% | $688K-19.4% | $854K-11.4% | $964K+21.9% | $791K |
| Gross Profit | $697K-20.6% | $878K+3.3% | $850K+2.6% | $828K-12.1% | $943K+29.6% | $727K-15.7% | $863K0.0% | $863K |
| R&D Expenses | $201K+21.7% | $165K+19.2% | $139K-10.7% | $156K+11.7% | $139K-7.9% | $151K+49.8% | $101K-40.1% | $168K |
| SG&A Expenses | $359K+9.3% | $328K-7.6% | $355K-4.9% | $373K+6.1% | $352K+0.1% | $352K-4.0% | $366K-5.8% | $389K |
| Operating Income | -$258K-1206.8% | -$20K+5.2% | -$21K+86.9% | -$159K-660.7% | $28K+115.0% | -$189K-3237.8% | $6K+104.7% | -$128K |
| Interest Expense | $11K-36.8% | $18K+89.4% | $10K-10.3% | $11K+66.4% | $6K-69.8% | $21K+25.0% | $17K+18.4% | $14K |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$268K-551.1% | -$41K-66.7% | -$25K+85.5% | -$170K-872.5% | $22K+110.6% | -$207K-2651.1% | -$8K+94.6% | -$140K |
| EPS (Diluted) | $-0.02 | $0.00 | $0.00+100.0% | $-0.01 | $0.00+100.0% | $-0.02 | $0.00+100.0% | $-0.01 |
ECIA Balance Sheet
| Metric | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.1M-1.8% | $4.1M+7.1% | $3.9M+9.5% | $3.5M-7.7% | $3.8M-10.9% | $4.3M-8.6% | $4.7M+19.8% | $3.9M |
| Current Assets | $2.4M-0.1% | $2.5M-8.8% | $2.7M+17.7% | $2.3M-9.2% | $2.5M-7.1% | $2.7M-10.6% | $3.0M+1.0% | $3.0M |
| Cash & Equivalents | $72K+49.7% | $48K-86.2% | $348K+51.3% | $230K-14.9% | $270K+172.5% | $99K-67.6% | $306K+134.4% | $131K |
| Inventory | $1.5M-4.3% | $1.5M+12.6% | $1.4M+17.1% | $1.2M-11.6% | $1.3M-15.2% | $1.6M-5.4% | $1.6M-12.0% | $1.9M |
| Accounts Receivable | $762K+1.7% | $749K-3.9% | $780K-4.5% | $817K+0.1% | $816K-11.6% | $923K-9.9% | $1.0M+12.2% | $913K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.2M-12.7% | $2.5M+15.6% | $2.2M+19.2% | $1.8M-7.1% | $2.0M-6.4% | $2.1M-9.6% | $2.3M+49.6% | $1.5M |
| Current Liabilities | $1.1M-16.1% | $1.3M-20.7% | $1.6M+41.4% | $1.1M-4.1% | $1.2M+12.0% | $1.1M-8.8% | $1.2M+4.1% | $1.1M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.9M+15.0% | $1.6M-3.9% | $1.7M-0.9% | $1.7M-8.5% | $1.9M-15.2% | $2.2M-7.6% | $2.4M+0.2% | $2.4M |
| Retained Earnings | -$23.1M-1.2% | -$22.8M-0.4% | -$22.7M-0.1% | -$22.7M-0.8% | -$22.5M-1.4% | -$22.2M-0.9% | -$22.0M0.0% | -$22.0M |
ECIA Cash Flow Statement
| Metric | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$127K-9.6% | -$116K-152.0% | -$46K-161.0% | $75K-36.0% | $118K-25.8% | $158K+264.3% | $43K+193.5% | -$46K |
| Capital Expenditures | $37K+461.3% | $7K-65.2% | $19K-33.9% | $28K+100.9% | $14K+18.6% | $12K+9677.9% | $122 | $0 |
| Free Cash Flow | -$163K-33.8% | -$122K-88.9% | -$65K-238.2% | $47K-54.8% | $103K-29.4% | $146K+237.8% | $43K+193.3% | -$46K |
| Investing Cash Flow | -$48K-625.0% | -$7K+73.2% | -$25K+38.3% | -$40K-106.6% | -$20K-27.1% | -$15K+5.9% | -$16K-3176.6% | -$499 |
| Financing Cash Flow | $199K+327.8% | -$87K-146.3% | $189K+350.8% | -$75K-157.9% | $130K+137.2% | -$350K-335.7% | $148K+1393.7% | -$11K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ECIA Financial Ratios
| Metric | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6%-9.2pp | 54.8%+1.2pp | 53.6%+6.4pp | 47.2%-10.6pp | 57.8%+11.8pp | 46.0%-1.3pp | 47.2%-5.0pp | 52.2% |
| Operating Margin | -16.9%-15.7pp | -1.2%+0.1pp | -1.3%+7.7pp | -9.0%-10.8pp | 1.7%+13.7pp | -12.0%-12.3pp | 0.3%+8.1pp | -7.7% |
| Net Margin | -17.5%-15.0pp | -2.6%-1.0pp | -1.6%+8.1pp | -9.7%-11.1pp | 1.4%+14.5pp | -13.1%-12.7pp | -0.4%+8.1pp | -8.5% |
| Return on Equity | N/A | N/A | N/A | N/A | 1.2% | N/A | N/A | N/A |
| Return on Assets | -6.6%-5.6pp | -1.0%-0.4pp | -0.6%+4.2pp | -4.8%-5.4pp | 0.6%+5.4pp | -4.8%-4.7pp | -0.2%+3.4pp | -3.6% |
| Current Ratio | 2.28+0.4 | 1.92+0.3 | 1.67-0.3 | 2.00-0.1 | 2.11-0.4 | 2.55-0.1 | 2.60-0.1 | 2.68 |
| Debt-to-Equity | 1.18-0.4 | 1.55+0.3 | 1.29+0.2 | 1.07+0.0 | 1.05+0.1 | 0.95-0.0 | 0.98+0.3 | 0.65 |
| FCF Margin | -10.7%-3.1pp | -7.6%-3.5pp | -4.1%-6.7pp | 2.7%-3.7pp | 6.3%-2.9pp | 9.3%+6.9pp | 2.4%+5.2pp | -2.8% |
Similar Companies
Frequently Asked Questions
What is Encision's annual revenue?
Encision (ECIA) reported $6.6M in total revenue for fiscal year 2025. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Encision's revenue growing?
Encision (ECIA) revenue declined by 0.5% year-over-year, from $6.6M to $6.6M in fiscal year 2025.
Is Encision profitable?
No, Encision (ECIA) reported a net income of -$220K in fiscal year 2025, with a net profit margin of -3.4%.
What is Encision's earnings per share (EPS)?
Encision (ECIA) reported diluted earnings per share of $-0.02 for fiscal year 2025. This represents a 66.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Encision's EBITDA?
Encision (ECIA) had EBITDA of -$91K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Encision's gross margin?
Encision (ECIA) had a gross margin of 53.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Encision's operating margin?
Encision (ECIA) had an operating margin of -2.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Encision's net profit margin?
Encision (ECIA) had a net profit margin of -3.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Encision's free cash flow?
Encision (ECIA) generated -$109K in free cash flow during fiscal year 2025. This represents a -182.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Encision's operating cash flow?
Encision (ECIA) generated -$55K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Encision's total assets?
Encision (ECIA) had $3.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Encision's capital expenditures?
Encision (ECIA) invested $54K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Encision spend on research and development?
Encision (ECIA) invested $593K in research and development during fiscal year 2025.
How many shares does Encision have outstanding?
Encision (ECIA) had 12M shares outstanding as of fiscal year 2025.
What is Encision's current ratio?
Encision (ECIA) had a current ratio of 1.66 as of fiscal year 2025, which is generally considered healthy.
What is Encision's debt-to-equity ratio?
Encision (ECIA) had a debt-to-equity ratio of 1.22 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Encision's return on assets (ROA)?
Encision (ECIA) had a return on assets of -6.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Encision's cash runway?
Based on fiscal year 2025 data, Encision (ECIA) had $257K in cash against an annual operating cash burn of $55K. This gives an estimated cash runway of approximately 56 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Encision's Piotroski F-Score?
Encision (ECIA) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Encision's earnings high quality?
Encision (ECIA) has an earnings quality ratio of 0.25x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Encision cover its interest payments?
Encision (ECIA) has an interest coverage ratio of -3.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Encision?
Encision (ECIA) scores 28 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.